New York charges Teva, Allergan with insurance fraud over opioid claims

New York state filed civil charges on Tuesday accusing Teva Pharmaceutical Industries Ltd and Allergan Plc with insurance fraud for downplaying the risks of their opioid painkillers to patients and doctors.

Stocks rally on new U.S. highs, dollar at two-year low

Global equities edged higher and the dollar fell to two-year lows on Tuesday as the broad U.S. stock market scaled new peaks helped by better-than-expected corporate earnings by retailers such as Walmart reporting record online sales.

S&P 500 hits new intraday record, regaining pre-COVID levels

The S&P 500 climbed to a record on Tuesday, surpassing a level hit in February before the coronavirus crisis and crowning one of the most dramatic recoveries in the index's history.

Citigroup asks judge to freeze funds it mistakenly sent to Revlon creditors

Citigroup asked a U.S. judge on Tuesday to freeze funds it mistakenly sent Revlon Inc creditors amid a lawsuit over one of the largest clerical errors by a bank in years.

Kohl's signals slow start to second half on weak back-to-school sales, shares drop

Kohl's Corp signaled a slow start to the current quarter on Tuesday, as the department store chain discounts heavily and grapples with weak demand as fewer schools reopen due to the COVID-19 pandemic, sending its shares down nearly 16%.

Home Depot posts record sales as demand for DIY products surges

Home Depot Inc reported its biggest rise in quarterly same-store sales in at least two decades on Tuesday as demand for paint, tools and lawn mowers surged from consumers stuck at home due to the COVID-19 pandemic.

Britain's M&S to cut 7,000 jobs in latest blow to retail sector

Marks & Spencer will cut a further 7,000 jobs, it said on Tuesday, as the COVID-19 crisis deals another blow to Britain's beleaguered retail sector.

Big Tech drives S&P 500 to record high in coronavirus rally

The S&P 500 hit a record high on Tuesday, thanks largely to months of outperformance from Amazon and other heavyweight technology companies viewed by investors as likely to emerge from the coronavirus crisis stronger than smaller rivals.

U.S. states seek $26.4 billion from drug firms in opioid litigation: WSJ

U.S. states are seeking a combined $26.4 billion from three major drug distributors and Johnson & Johnson to settle opioid litigation against the companies, the Wall Street Journal reported on Tuesday, citing people familiar with the matter.

Apple expands independent repair shop program to Mac computers

(This Aug 17 story fixes reversed words in title of Public Interest Research Group in paragraph 7.)

Related Videos

U.S. states seek $2.2 trillion from Purdue Pharma

U.S. again tightens restrictions on Huawei

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS